Feasibility of tocilizumab in ICU patients with COVID-19

J Med Virol. 2021 Jan;93(1):46-47. doi: 10.1002/jmv.26110. Epub 2020 Aug 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Cytokine Release Syndrome
  • Feasibility Studies
  • Humans
  • Intensive Care Units
  • Receptors, Interleukin-6
  • SARS-CoV-2*

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab